It was a pleasure to read the article from Verret et al. in a recent issue of Anesthesiology.1 The main prerequisites of a high-quality systematic review were met; however, some considerations about the patient, intervention, comparison, and study design approach applied and the conclusion of the review must be addressed. The main outcomes of the meta-analysis pooled results of highly divergent procedures, from endoscopic procedures to major surgeries. A relevant issue in both the Enhanced Recovery after Surgery and the Perioperative Surgical Home doctrines is the specificity of surgical route standardization.2,3 The possibility of another analgesic regiment being used in the comparator group is another concern. The use of gabapentin was compared with antidepressants, opioids, ketamine, nonsteroidal anti-inflammatory drugs, corticosteroids, benzodiazepines, neuroleptics, anticonvulsant, α2-adrenergic receptor agonists, paracetamol, melatonin, and placebo....
Perioperative Use of Gabapentinoids: Comment
(Accepted for publication December 7, 2020. Published online first on January 6, 2021.)
- Views Icon Views
- Share Icon Share
- Search Site
Bruno Luís de Castro Araujo; Perioperative Use of Gabapentinoids: Comment. Anesthesiology 2021; 134:664 doi: https://doi.org/10.1097/ALN.0000000000003666
Download citation file: